ÂÜÀòÂÒÂ×

Hendrik-Tobias Arkenau is the Executive Medical Director of the Sarah Cannon Research Institute UK (SCRI UK) and Clinical Lead for the Hospital Corporation of America International Cancer Service Line. Since founding the SCRI UK in 2010, he has built a portfolio of over 180 early-stage cancer clinical trials. He is a Fellow of the Royal College of Physicians.